User Fee Inches Closer to Reauthorization During its mark-up session on April 25, the Senate’

User Fee Inches Closer to Reauthorization
During its mark-up session on April 25, the Senate’s Health Education and Labor Committee voted to move the U.S. Food and Drug Adminstration’s user fee reauthorization legislation to the U.S. Senate floor for a full vote. A mark up also was scheduled in the U.S. House of Representatives, but has been delayed (and was not held as of press time). The delay could be due to squabbling between Democrats and Republicans about medical device approval language.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters